UNSPSC 51285806: Opiniazide

This classification denotes an antitubercular agent with the molecular formula C16H15N3O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KD4681N5W4, chemically known as 5,6-dimethoxyphthalaldehydic acid isonicotinoylhydrazone but more generally known as opiniazide, which bears US NIH Compound Identifier 6871212. European Medicines Agency schedules Opiniazide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09449MIG.

The term OPINIAZIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 19 1975, List 5). OPINIAZIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: O(C1C(C(CCC1OC)/C=N/NC(=O)C1CCNCC1)C(=O)O)C.

UNSPSC 51285806 Opiniazide, a Commodity code, shows activity in pharmaceutical procurement by state and local health agencies, though the recent record reflects a mismatch between the code's nominal scope and the work actually being bought. The Illinois Department of Public Health awarded a $2.999999 million piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for antibiotic warehouse supply—Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets—under a 12-month initial term with two renewal options. Seminole County, Florida issued an IFB in June 2026 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to its Community Health Building in Sanford. These solicitations demonstrate that state and local procurement officers are using this code for emergency pharmaceutical and medical-supply contracting, not specifically for the opiniazide compound the code nominally names. The issuing bodies span state health departments and county public health functions, both engaged in routine supply-chain procurement through cooperative purchasing vehicles and competitive bid processes.

The recent activity clusters in Illinois and Florida. The Illinois award represents completed procurement through a pharmaceutical warehouse piggyback arrangement with no set-aside requirements or domestic preferences; the Seminole County opportunity remains active and introduces potential FEMA funding compliance, E-Verify requirements, drug-free workplace certification, and a three-month probationary termination clause. Neither opportunity specifies disadvantaged-enterprise set-asides. The Illinois contact is Mike Caceres at the Illinois Department of Public Health, 217-577-7905. Vendors pursuing this code should note that actual state and local demand has diverged from the opiniazide Commodity descriptor, clustering instead around broad-spectrum antibiotics and emergency-response medications procured through standard cooperative-purchasing vehicles with quarterly or annual supply arrangements.